Globo Pharma

What Globo Pharma does

Globo Pharma (legal name: GLOBO PHARMA) is a privately held Brazilian pharmaceutical manufacturer founded in 1954 and headquartered in the Belo Horizonte metropolitan area, where it operates an integrated 41,000 m2 (440,000+ sq ft) manufacturing campus comprising production facilities, laboratories, and on-site wastewater treatment. The company produces a portfolio of more than 89 medications across 260 presentations spanning generics, proprietary branded products, and food/dietary supplements, distributed across therapeutic categories that include antihistamines/antiallergics, anti-infectives, anti-inflammatories and analgesics, dermatologicals, cardiovascular, digestive, nervous system, and respiratory medications.

The business model is B2B-to-B2C: Globo Pharma manufactures and sells through pharmacy retail networks, points of sale, and wholesale distributors across Brazil, with a dedicated São Paulo office serving as the partnership coordination hub. The GTM motion combines a sales-led push through retail pharmacy and distribution channels with an explicitly partnership-driven growth lever, via a Business Development department that pursues national and international co-development, technology transfer, and product pipeline expansion. Revenue streams consist of one-time sales of generics, branded medications, and food supplements; pricing is not publicly disclosed.

Operations are supported by an in-house R&D function with state-of-the-art laboratory infrastructure and a multidisciplinary team of scientists, pharmacists, and regulatory experts that develops new formulations and optimizes existing products. The company maintains LGPD-compliant (Brazilian data protection law) operations, positions sustainability as a stated pillar, and uses a corporate website and LinkedIn for top-of-funnel presence; the underlying technical stack is conventional pharmaceutical manufacturing with no disclosed AI, software platform, or digital health product. Ownership structure, investors, revenue figures, and M&A history are not publicly disclosed, and no funding rounds or subsidiaries are reported.

Name

Globo Pharma

Legal name

GLOBO PHARMA

Website

https://globopharma.com.br

Company type

Private

Founded year

1954

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Globo Pharma is a privately held Brazilian pharmaceutical manufacturer founded in 1954 that produces 89+ generic, branded, and supplement medications across 260 presentations for distribution through pharmacy retail and wholesale channels within Brazil.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA), Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Generic pharmaceuticals
• Branded medications
• Pharmaceutical manufacturing
• Food supplements
• Therapeutic medicines

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Generic Medications: Sale of generic pharmaceutical products - cost-effective alternatives to branded medications making healthcare accessible to broader populations
2. Branded Medications: Sale of proprietary branded pharmaceutical products under the company's own brand portfolio
3. Food Supplements: Sale of dietary and food supplement products including dermatological supplements and other health-related supplements

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Globo Pharma manufactures and sells a portfolio of generic and branded pharmaceutical products, alongside food supplements, covering therapeutic categories including antihistamines, anti-infectives, anti-inflammatories/analgesics, dermatologicals, cardiovascular, digestive, nervous, and respiratory system medications. The company operates its own manufacturing facility in Belo Horizonte and distributes products through pharmacy retail and wholesale channels across Brazil.

Product overview

Globo Pharma is a Brazilian pharmaceutical company established in 1954, offering a diverse portfolio of generic medications and proprietary branded products. The company manufactures over 89 medications in 260 presentations across therapeutic categories including antihistamines/antiallergics, anti-infectives, anti-inflammatories/analgesics/muscle relaxants, dermatologicals, cardiovascular, digestive system, nervous system, and respiratory system medications. Additionally, the company offers food supplements and other health products. The product portfolio is distributed through generics (bioequivalent medications at accessible prices), proprietary branded products under the company's own brands, and food/nutritional supplements.

Differentiator

Problem solved

Functional benefit

Brands

• Generics: Generic pharmaceutical products offered by Globo Pharma.
• Nossas Marcas (Our Brands)

Products and services

• Generics (Genéricos)

Quantifiable outcome

• 89+ medications and 260 presentations in portfolio
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• National PartnerscoreStrategic or Co-development PartnerStrategic partnerships with national partners for product development and market expansion. The Business Development department builds partnerships and development networks with domestic Brazilian partners to identify new products that meet market demand and consumer needs.
• International PartnerscoreStrategic or Co-development PartnerInternational partnerships for pharmaceutical product development and technology exchange. These partnerships facilitate constant exchange of technology and know-how, enhancing quality standards and market positioning.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Eurofarma Laboratórios: Eurofarma is one of the largest Brazilian pharmaceutical companies with a diversified generics, branded, and specialty portfolio across therapeutic categories and active in national and international partnerships. Comparable to Globo Pharma in breadth of portfolio, manufacturing scale in Brazil, and cross-category therapeutic coverage.
• EMS Pharma: EMS is Brazil's largest pharmaceutical company and the leading generics manufacturer in the country, operating a broad branded and generic portfolio across multiple therapeutic categories sold through Brazilian pharmacy retail. Directly comparable to Globo Pharma in product mix, distribution model, and end-market focus.
• Medley (Sanofi): Medley is a Brazilian generic pharmaceutical brand, originally a major independent generics player and now part of Sanofi, distributing through Brazilian pharmacy retail. Directly comparable to Globo Pharma in generics-led portfolio and Brazil-centric pharmacy distribution model.
• Aché Laboratórios Farmacêuticos: Aché is an established Brazilian pharmaceutical manufacturer with a broad portfolio spanning prescription, OTC, and generics distributed through pharmacy channels. Directly comparable to Globo Pharma in operating model, Brazilian retail-channel focus, and multi-category therapeutic breadth.
• Biolab Farmacêutica: Biolab is a Brazilian pharmaceutical manufacturer with a diversified portfolio spanning prescription, OTC, generics, and hospital products, distributed nationally through pharmacy and institutional channels. Comparable in portfolio breadth, manufacturing-driven business model, and growth-oriented positioning in the Brazilian pharma market.
• Cimed Indústria de Medicamentos: Cimed is a Brazilian pharmaceutical company with a generics and OTC portfolio sold via pharmacy retail and strong emphasis on affordable access. Comparable to Globo Pharma in generics-led positioning, scale of manufacturing footprint, and Brazilian mass-market retail distribution strategy.
• Prati-Donaduzzi: Prati-Donaduzzi is one of Brazil's largest generic pharmaceutical manufacturers, with significant manufacturing capacity and a focus on affordable generic medicines distributed nationally via pharmacy retail. Comparable to Globo Pharma in generics-led business, large manufacturing footprint, and Brazilian market focus.
• Hyper Pharma (Hyper marcas SA): Hyper Pharma is a Brazilian pharmaceutical company focused on accessible medicines and consumer health products distributed through pharmacy retail. Strongly comparable to Globo Pharma in affordability positioning, generic-plus-OTC mix, and reliance on Brazilian pharmacy channel distribution.

Broad incumbents

• Sandoz (Novartis): Sandoz is the global generic and biosimilar pharmaceutical arm of Novartis, the worldwide leader in off-patent medicines. Comparable to Globo Pharma as a broad incumbent in the generic pharmaceutical manufacturing category with a much larger global footprint and broader product range.

Emerging players

• Torrent Pharmaceuticals: Torrent Pharmaceuticals is an emerging global generic pharmaceutical manufacturer headquartered in India with growing international presence across emerging markets including Brazil. Comparable to Globo Pharma in generics-led strategy, multi-therapeutic category coverage, and active pursuit of international partnerships for portfolio expansion.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/globo-pharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Globo Pharma